Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds angiotensin-converting enzyme 2 (ACE2) on host cells to initiate entry, and soluble ACE2 is a therapeutic candidate that neutralizes infection by acting as a decoy. By using deep mutagenesis, mutations in ACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kui K., Dorosky, Danielle, Sharma, Preeti, Abbasi, Shawn A., Dye, John M., Kranz, David M., Herbert, Andrew S., Procko, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574912/
https://www.ncbi.nlm.nih.gov/pubmed/32753553
http://dx.doi.org/10.1126/science.abc0870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574912/
https://www.ncbi.nlm.nih.gov/pubmed/32753553
http://dx.doi.org/10.1126/science.abc0870

Ejemplares similares